BioSpace News Archive

Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that an overview of the Company’s proprietary Lm platform and new information regarding the Company’s neoantigen-directed therapy programs, ADXS-NEO (customized, personalized neoantigens) and ADXS-HOT

The Green Organic Dutchman Holdings Ltd. would like to comment on the Greek Ministry of Agriculture’s press release and CNN’s coverage dated Jan 25, 2019

Rubicon Organics Inc. (CSE:ROMJ) (OTCQX:ROMJF) (“Rubicon Organics” or the “Company”), a super-premium, organic cannabis company with operations in Canada, Washington and California, confirms that it is in active communications with Health Canada and has responded to all inquiries received to date with respect to its wholly-owned, 125,000 sq. ft. greenhouse facility in Delta, BC.

Dr. Xin has more than 20 years of oncology drug discovery and clinical development experience in biotech and large biopharma companies for indications in solid tumors and hematologic malignancies, in a variety of therapeutic modalities

I-Mab Biopharma (“I-Mab”), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases, announces on Jan. 25, 2019 that its IND application for TJC4, has been approved by the US Food & Drug Administration (FDA).

Pharmaceutical Company Highlights Past Achievements, Future Endeavors

Magnolia Health Hosts Back-To-School Events to Help Promote EPSDT Screenings

“ADO remains in Berlinger portfolio”

MRM Proteomics Inc. and Biodesix® have inked a partnership to create novel assays to answer critical clinical questions within the lung cancer continuum of care.

NIC Inc. (Nasdaq: EGOV), the nation’s leader of innovative digital government solutions, has been selected to provide its RxGov prescription drug monitoring platform to the State of Maryland to help combat the prescription opioid epidemic. F